In addition to the presenter, following authors who may have helped with the content writing, review, or approval declare no conflict of interest.
In this discussion we will review the mechanism of Ivermectin against mutating SARS-COV-2.
These mechanisms are potential mechanisms observed in-silico, in-vitro, or in-vivo.
1. Ivermectin continues to bind with the Spike protein of the SARS-COV-2.
2. How ivermectin disrupts the viral replication by disrupting RdRp and 3-CTLP?
3. How ivermectin continues to help the cell produce interferons, regardless of the varaint?
4. How ivermectin continues to work on the nuclear factor kapp beta pathway?
Mobeen Syed M.D, MS Graduated from King Edward Medical University. Entrepreneur, Medical Educator, CEO and founder of Drbeen corp.